High Risk Hematologic Disorders
1 clinical trials · Condition
◉ Watch High Risk Hematologic Disorders
| Record | Firm | Date |
|---|---|---|
| Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases (NCT03367546) | Masonic Cancer Center, University of Minnesota | 2018-07-02 |
Track High Risk Hematologic Disorders automatically
Every clearance here is in the API, with alerts when new ones post.